LADENBURG THALMANN FINANCIAL SERVICES INC. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 67 filers reported holding CTI BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$01,2030.0%0.00%
Q3 2016$01,203
+0.1%
0.00%
Q2 2016$0
-100.0%
1,2020.0%0.00%
Q1 2016$1,0000.0%1,2020.0%0.00%
Q4 2015$1,000
-50.0%
1,202
-5.2%
0.00%
Q3 2015$2,0000.0%1,2680.0%0.00%
Q2 2015$2,0000.0%1,268
-8.5%
0.00%
Q1 2015$2,000
-33.3%
1,386
+9.5%
0.00%
Q4 2014$3,0000.0%1,2660.0%0.00%
Q3 2014$3,000
-25.0%
1,2660.0%0.00%
Q2 2014$4,0001,2660.00%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2016.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders